Health & Biotech
Health & Biotech
ASX Health Stocks: Pharmaxis jumps 9pc on FDA approval
Health & Biotech
China is about to grant patents like never before, and these ASX stocks have already got some
Health & Biotech
Aegros pockets license from TGA and flags capital raising, as it aims to disrupt the $19bn plasma market
Health & Biotech
Creso Pharma’s subsidiary Halucenex’s key psychedelic ingredient passes crucial testing and is one step closer to phase two clinical trials
Health & Biotech
ASX Health Stocks: USCOM jumps 12pc on China patent, while Next Science gets TGA nod
Health & Biotech
ScoPo’s Powerplays: Investors become a ‘little more picky’ as markets continue to push ever higher
Health & Biotech
ASX Health Stocks: Visioneering jumps 13pc on contact lenses launch, Sigma drops bid for API
Health & Biotech
MoneyTalks: Canary Capital’s Paul Hart is bullish about the biotech sector – here’s why
Health & Biotech
TALi Digital’s treatment for ADHD given major endorsement through key healthcare organisation
Health & Biotech
ASX Health: Invex gets ready for Phase 3, Medlab gets US patent. Both jump 13pc this morning
Health & Biotech
BluView: Investors bullish on cannabis sector, and its pot stocks worth watching
Health & Biotech
Apiam confirms APVMA approval for a critical new vaccine in a major breakthrough for Australian cattle health
Health & Biotech
ASX Health Stocks: Paradigm rockets 21pc after getting FDA nod, Memphasys up 31pc on imminent launch
Health & Biotech
Strong FY21 results underpin EZZ’s foothold in growing life sciences sector
Health & Biotech
MGC Pharma opens new production facility in Malta, now set to ramp up sales of CimetrA
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.